BBIO announcements Bridgebio Pharma Inc announcements and dividends declared NASDAQ

Bridgebio Pharma Inc Complete list of announcements declared & dividend announcements by Bridgebio Pharma Inc BBIO

Bridgebio Pharma Inc BBIO listed on NASDAQ and deals in

Announcements and dividends declared by Bridgebio Pharma Inc BBIO

BridgeBio Pharma Presents Positive Data From CANaspire Phase 1/2 Study In Canavan Disease
(RTTNews) - BridgeBio Pharma, Inc. (BBIO) Thursday reported positive preliminary data from the CANaspire Phase 1/2 study of its gene therapy candidate, BBP-812 for the treatment of Canavan disease, a rare genetic neurological disorder.
Announcement as on 24 October 2024

Oppenheimer Initiates Coverage of BridgeBio Pharma (MUN:2CL) with Perform Recommendation
Fintel reports that on October 3, 2024, Oppenheimer initiated coverage of BridgeBio Pharma (MUN:2CL) with a Perform recommendation.
Announcement as on 06 October 2024

BridgeBio Pharma Commences Public Offering Of 0 Mln Of Shares; Stock Down
(RTTNews) - BridgeBio Pharma Inc. (BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, said that it has commenced an underwritten public offering of 0 million of shares of its common stock.
Announcement as on 05 March 2024

: BridgeBio Pharma shares gain on trial results for dwarfism drug
Shares of BridgeBio Pharma Inc. BBIO gained 5.5% premarket on Tuesday after the company announced that its investigational treatment for children with achondroplasia, a bone growth disorder that causes disproportionate short stature, resulted in significan
Announcement as on 20 June 2023

BridgeBio Pharma (BBIO) Gains As Market Dips: What You Should Know
BridgeBio Pharma (BBIO) closed the most recent trading day at .02, moving +0.1% from the previous trading session. The stock outpaced the S&P 500's daily loss of 2.77%. Elsewhere, the Dow lost 2.82%, while the tech-heavy Nasdaq lost 0.83%.
Announcement as on 22 April 2022

Announcements by Bridgebio Pharma Inc first page | Next page |

BBIO Bridgebio Pharma Inc current price & indicator signals

Moving Averages for Bridgebio Pharma Inc

5Day Average: 34.64
12Day Average: 35.12
20Day Average: 33.92
50Day Average: 32.79
100Day Average: 29.11
150Day Average: 28.16
200Day Average: 27.92

BBIO Indicators & signals

Indicator MACD (12,26,9)

34.74, 34.17, 0.71
Indicator MACD is in positive zone

Indicator ADX (14)

1.23, 20.92, 20.41
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of BBIO Bridgebio Pharma Inc are as follows: Daily volume is divided by 10 day averaged volume

Date	Close	Range	Change %	Volume
28 Fri Feb 2025	34.90	33.45 to 34.99	1.9%	0.54 times
27 Thu Feb 2025	34.25	33.36 to 35.02	2.39%	0.86 times
26 Wed Feb 2025	33.45	33.04 to 35.01	-2.62%	1.9 times
25 Tue Feb 2025	34.35	32.50 to 35.46	-5.24%	1.44 times
24 Mon Feb 2025	36.25	35.53 to 37.50	-1.63%	0.37 times
21 Fri Feb 2025	36.85	36.39 to 38.05	0.11%	0.53 times
20 Thu Feb 2025	36.81	35.36 to 39.47	1.43%	1.54 times
19 Wed Feb 2025	36.29	35.41 to 36.59	0%	0.89 times
19 Wed Feb 2025	36.29	35.41 to 36.59	2.25%	0.89 times
18 Tue Feb 2025	35.49	33.86 to 36.07	1.69%	0.85 times
14 Fri Feb 2025	34.90	31.63 to 34.99	10.58%	0.72 times
13 Thu Feb 2025	31.56	31.22 to 32.64	-1.22%	0.37 times